Company record
Brandywine Pharmaceuticals, LLC
0 FDA warning letters since 2023 and 2 recalls in the last 12 months.
Get an email the day FDA posts anything new about Brandywine Pharmaceuticals, LLC.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Nov 4 | Class II | Brandywine Pharmaceuticals, LLC Drug |
Theophylline Extended-Release Tablets, 100 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-500-10 CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory |
| Nov 4 | Class II | Brandywine Pharmaceuticals, LLC Drug |
Theophylline Extended-Release Tablets, 200 mg, Rx Only, 100-count bottle, Distributed by: Brandywine Pharmaceuticals, LLC, West Chester, PA 19382, NDC: 71321-501-10. CGMP Deviations: interruption in the ongoing stability testing program conducted at a third-party laboratory |